Leica Biosystems

Anti-bcl-2 Oncoprotein Monoclonal Antibody, Unconjugated

#NCL-bcl-2 · western blot

16
Citing papers
653
Combined citations
Supplier page Find this product

Research areas

Cell death mechanisms and regulation5Cancer-related Molecular Pathways4Cancer Research and Treatments2Autophagy in Disease and Therapy1Cancer, Lipids, and Metabolism1Cardiac and Coronary Surgery Techniques1Cancer, Hypoxia, and Metabolism1Antimicrobial Peptides and Activities1

Papers citing this product

1
Fas and Fas Ligand Are Up-Regulated in Pulmonary Edema Fluid and Lung Tissue of Patients with Acute Lung Injury and the Acute Respiratory Distress Syndrome
American Journal Of Pathology·2002·290 cit.·DOI
2
Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients
British Journal of Cancer·2007·101 cit.·DOI
3
Escherichia coli induces apoptosis and proliferation of mammary cells
Cell Death and Differentiation·2001·98 cit.·DOI
4
Cancer cells surviving hypoxia obtain hypoxia resistance and maintain anti‐apoptotic potential under reoxygenation
International Journal of Cancer·2001·51 cit.·DOI
5
Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent ‘type I’ mode
Cell Death and Disease·2013·46 cit.·DOI
6
Caspase-3 and Bcl-2 expression in glioblastoma: an immunohistochemical study
Arquivos de Neuro-Psiquiatria·2010·38 cit.·DOI
7
Expression of growth regulatory genes in a SCID mouse-human model of intestinal epithelial regeneration
The Journal of Pathology·1999·13 cit.·DOI
8
Expression of apoptosis in human saphenous vein grafts in restoration of blood flow through coronary bypass surgery
Brazilian Journal of Cardiovascular Surgery·2009·6 cit.·DOI
9
Effect of nucleolin on adriamycin resistance via the regulation of B‐cell lymphoma 2 expression in Burkitt's lymphoma cells
Journal of Cellular Physiology·2019·4 cit.·DOI
10
c-kit and bcl-2 Are Not Useful Markers in Differentiating Adenoid Cystic Carcinoma from Polymorphous Low-Grade Adenocarcinoma
ISRN Pathology·2011·3 cit.·DOI

Also available from other vendors

This target has 177 citing papers across all vendors combined

VendorProductPricePapers
Leica BiosystemsAnti-bcl-2 Oncoprotein Monoclonal Antibody, Unconjugated—1
Leica BiosystemsAnti-bcl-2 Oncoprotein Monoclonal Antibody, Unconjugated—2
Leica BiosystemsAnti-bcl-2 Oncoprotein Monoclonal Antibody, Unconjugated—6
DSHBBCL2-like 2 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157
DSHBBCL2-like 2 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157
DSHBBCL2 like 1 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—1
DSHBBCL2 like 1 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157
DSHBBCL2 like 1 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157
DSHBBCL2-like 2 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157

Similar products

ProductVendorPricePapers
Anti-bcl-2 Oncoprotein Monoclonal Antibody, UnconjugatedLeica Biosystems—6
Anti-bcl-2 Oncoprotein Monoclonal Antibody, UnconjugatedLeica Biosystems—2
Anti-bcl-2 Oncoprotein Monoclonal Antibody, UnconjugatedLeica Biosystems—1